M&As Aren't Enough: Why Pharmaceutical Companies Need New Business Models

Nabila Amarsy

November 19, 2015

#

min read

topics

Business Model Canvas

Business Models

Health

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

_{Music: Matti Palanen, 'Clouds fly with me'}

No items found.

related reads

About the speakers

Nabila Amarsy

by

Nabila Amarsy

November 19, 2015

1
2
3

related reads

Explore more innovation insights in our knowledge library

Let's talk

Whether you’re looking for more information or you’re ready to start a project, we’re ready to help.

Thanks for your interest in our solutions. We will be in touch with you soon.

November 19, 2015

#

min read

topics

Business Model Canvas

Business Models

Health

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

_{Music: Matti Palanen, 'Clouds fly with me'}

related reads

M&As aren't enough: why pharmaceutical companies need new business models

Merger and acquisitions have boomed in the pharmaceutical industry these past few years. In this video, I illustrate the motives behind these M&As, why they're not enough to drive long-term growth, and how pharma companies can address the key challenges of their industry.

Thanks for your interest in

M&As aren't enough: why pharmaceutical companies need new business models

M&As aren't enough: why pharmaceutical companies need new business models

ONLINE COURSe

Let's talk

Whether you’re looking for more information or you’re ready to start a project, we’re ready to help.

Thanks for your interest in our solutions. We will be in touch with you soon.